Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Data(s) |
2009
|
---|---|
Resumo |
BACKGROUND:It is unknown whether specific viral polymorphisms affect in vivo therapeutic response in patients with cytomegalovirus (CMV) disease. Polymorphisms in the CMV glycoprotein B (gB) gene allow discrimination of 4 distinct genotypes (gB1-gB4). We assessed the influence of gB genotypes on the clinical and virologic outcome of CMV disease. METHODS:Solid-organ transplant recipients enrolled in a multicenter trial of CMV disease treatment (VICTOR study) were included in this study. CMV gB genotyping was performed using quantitative real-time polymerase chain reaction at day 0 (start of antiviral therapy). RESULTS:Among 239 patients with CMV disease, the prevalence of gB strain types was 26% for gB1, 10% for gB2, 10% for gB3, and 5% for gB4, whereas mixed infections were present in 49%. Donor-seropositive/recipient-seropositive patients were more likely to have mixed gB infection than donor-seropositive/recipient-seronegative patients (40% vs. 12%; P = .001). Median baseline viral loads were higher and time to viral eradication was longer ( P = .006 and P = .026 , respectively) for mixed infection versus infection with a single genotype. In a multivariate model, mixed gB infection was a significant predictor of failure to eradicate virus by day 21 (mixed vs single genotype; odds ratio, 2.66; 95% confidence interval, 1.31-5.38; P = .007 ) after controlling for baseline viral load, CMV serostatus at baseline, ganciclovir resistance, and antiviral treatment. No effect of gB genotype was seen on virologic or clinical CMV recurrence. CONCLUSIONS:No specific gB genotype appears to confer a specific CMV virulence advantage. However, mixed gB genotype infections are associated with higher viral loads and delayed viral clearance. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_0C9239A22849 isbn:1537-6591[electronic] pmid:19751151 doi:10.1086/605633 isiid:000270230100004 |
Idioma(s) |
en |
Fonte |
Clinical Infectious Diseases, vol. 49, no. 8, pp. 1160-1166 |
Palavras-Chave | #Adult; Cytomegalovirus/genetics; Cytomegalovirus/pathogenicity; Cytomegalovirus Infections/virology; Female; Genotype; Humans; Male; Middle Aged; Organ Transplantation/adverse effects; Polymerase Chain Reaction/methods; Polymorphism, Genetic; Postoperative Complications/virology; Recurrence; Severity of Illness Index; Viral Envelope Proteins/genetics; Viral Load; Virulence |
Tipo |
info:eu-repo/semantics/article article |